PRRT2 and lymphoma: Unlike the pro-tumorigenic roles, TPA shows an opposing role in the proliferation as an anti-tumorigenic agent in lymphoma, liver cancer, and other types of tumor cells via activating the different PKC isoforms and the Hippo/YAP pathway [21,22,23].